Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
1357354-49-4 | 2-tert-Butyl 9-ethyl 2,7-diazaspiro[4.4]nonane-2,9-dicarboxylate | AA00HUAT | MFCD22209570
1367952-05-3 | 2-(Dimethylamino)oxazole-5-carboxylic acid | AA00HUMA | MFCD22069604
1379352-82-5 | 4-Bromo-7-chloro-1-methyl-1h-indole | AA00HV2F | MFCD08272260
1391733-77-9 | tert-Butyl 3-(aminomethyl)-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate | AA00HVDL | MFCD23378346
1402559-21-0 | tert-Butyl (4-amino-3-fluorophenyl)carbamate | AA00HVPU | MFCD09953034
141717-92-2 | Phenyl n-(2,5-dimethoxyphenyl)carbamate | AA00HW3D | MFCD14859466
1423037-56-2 | N-Butyl L-Z-isoleucinamide | AA00HWEB | MFCD14590311
1431546-20-1 | [2-fluoro-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetic acid | AA00HWQK | MFCD19288876
1445322-51-9 | 4-(2-Bromophenoxy)-3-fluoroaniline HCl | AA00HX07 | MFCD25121760
1449135-43-6 | 1,3-Dimethyl-5-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-thiophen-2-ylmethylene]-pyrimidine-2,4,6-trione | AA00HX7I | MFCD20527093